Your browser doesn't support javascript.
Systemic Perturbations in Amine and Kynurenine Metabolism Associated with Acute SARS-CoV-2 Infection and Inflammatory Cytokine Responses.
Lawler, Nathan G; Gray, Nicola; Kimhofer, Torben; Boughton, Berin; Gay, Melvin; Yang, Rongchang; Morillon, Aude-Claire; Chin, Sung-Tong; Ryan, Monique; Begum, Sofina; Bong, Sze How; Coudert, Jerome D; Edgar, Dale; Raby, Edward; Pettersson, Sven; Richards, Toby; Holmes, Elaine; Whiley, Luke; Nicholson, Jeremy K.
  • Lawler NG; Australian National Phenome Centre, Computational and Systems Medicine, Health Futures Institute, Murdoch University, Harry Perkins Building, Perth, WA 6150, Australia.
  • Gray N; Australian National Phenome Centre, Computational and Systems Medicine, Health Futures Institute, Murdoch University, Harry Perkins Building, Perth, WA 6150, Australia.
  • Kimhofer T; Australian National Phenome Centre, Computational and Systems Medicine, Health Futures Institute, Murdoch University, Harry Perkins Building, Perth, WA 6150, Australia.
  • Boughton B; Australian National Phenome Centre, Computational and Systems Medicine, Health Futures Institute, Murdoch University, Harry Perkins Building, Perth, WA 6150, Australia.
  • Gay M; Bruker Pty Ltd., Preston, VIC 3072, Australia.
  • Yang R; Australian National Phenome Centre, Computational and Systems Medicine, Health Futures Institute, Murdoch University, Harry Perkins Building, Perth, WA 6150, Australia.
  • Morillon AC; Australian National Phenome Centre, Computational and Systems Medicine, Health Futures Institute, Murdoch University, Harry Perkins Building, Perth, WA 6150, Australia.
  • Chin ST; Australian National Phenome Centre, Computational and Systems Medicine, Health Futures Institute, Murdoch University, Harry Perkins Building, Perth, WA 6150, Australia.
  • Ryan M; Australian National Phenome Centre, Computational and Systems Medicine, Health Futures Institute, Murdoch University, Harry Perkins Building, Perth, WA 6150, Australia.
  • Begum S; Australian National Phenome Centre, Computational and Systems Medicine, Health Futures Institute, Murdoch University, Harry Perkins Building, Perth, WA 6150, Australia.
  • Bong SH; Department of Metabolism Digestion and Reproduction, Faculty of Medicine, Imperial College London, Sir Alexander Fleming Building, South Kensington, London SW7 2AZ, U.K.
  • Coudert JD; Australian National Phenome Centre, Computational and Systems Medicine, Health Futures Institute, Murdoch University, Harry Perkins Building, Perth, WA 6150, Australia.
  • Edgar D; Centre for Molecular Medicine & Innovative Therapeutics, Murdoch University, Perth, WA 6150, Australia.
  • Raby E; State Adult Burn Unit, Fiona Stanley Hospital, Murdoch, WA 6150, Australia.
  • Pettersson S; Burn Injury Research Node, The University of Notre Dame, Fremantle, WA 6160, Australia.
  • Richards T; Fiona Wood Foundation, Murdoch, WA 6150, Australia.
  • Holmes E; Department of Microbiology, PathWest Laboratory Medicine, Perth, WA 6009, Australia.
  • Whiley L; Department of Infectious Diseases, Fiona Stanley Hospital, Perth, WA 6150, Australia.
  • Nicholson JK; Singapore National Neuro Science Centre, Singapore Mandalay Road, Singapore 308232, Singapore.
J Proteome Res ; 20(5): 2796-2811, 2021 05 07.
Article in English | MEDLINE | ID: covidwho-1387127
ABSTRACT
We performed quantitative metabolic phenotyping of blood plasma in parallel with cytokine/chemokine analysis from participants who were either SARS-CoV-2 (+) (n = 10) or SARS-CoV-2 (-) (n = 49). SARS-CoV-2 positivity was associated with a unique metabolic phenotype and demonstrated a complex systemic response to infection, including severe perturbations in amino acid and kynurenine metabolic pathways. Nine metabolites were elevated in plasma and strongly associated with infection (quinolinic acid, glutamic acid, nicotinic acid, aspartic acid, neopterin, kynurenine, phenylalanine, 3-hydroxykynurenine, and taurine; p < 0.05), while four metabolites were lower in infection (tryptophan, histidine, indole-3-acetic acid, and citrulline; p < 0.05). This signature supports a systemic metabolic phenoconversion following infection, indicating possible neurotoxicity and neurological disruption (elevations of 3-hydroxykynurenine and quinolinic acid) and liver dysfunction (reduction in Fischer's ratio and elevation of taurine). Finally, we report correlations between the key metabolite changes observed in the disease with concentrations of proinflammatory cytokines and chemokines showing strong immunometabolic disorder in response to SARS-CoV-2 infection.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 / Kynurenine Limits: Humans Language: English Journal: J Proteome Res Journal subject: Biochemistry Year: 2021 Document Type: Article Affiliation country: ACS.JPROTEOME.1C00052

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 / Kynurenine Limits: Humans Language: English Journal: J Proteome Res Journal subject: Biochemistry Year: 2021 Document Type: Article Affiliation country: ACS.JPROTEOME.1C00052